Literature DB >> 9067275

Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2.

J R Mestre1, K Subbaramaiah, P G Sacks, S P Schantz, T Tanabe, H Inoue, A J Dannenberg.   

Abstract

Cyclooxygenase-2 expression is up-regulated in transformed cells and tumors. Because this enzyme catalyzes the synthesis of prostaglandins, strategies aimed at suppressing its expression may prove useful in preventing or treating cancer. We investigated the ability of retinoids to suppress phorbol ester-mediated induction of cyclooxygenase-2 in human oral epithelial cells. Treatment with phorbol myristate acetate (PMA) resulted in approximately a 3-fold increase in the production of prostaglandin E2 (PGE2). Retinoids [all-trans-retinoic acid (RA), 13-cis-RA, and retinyl acetate] markedly suppressed PMA-mediated increases in amounts of cyclooxygenase-2 (Cox-2) and the production of PGE2. Retinoids also suppressed the induction of Cox-2 mRNA by PMA. Nuclear run-offs revealed increased rates of Cox-2 transcription after treatment with PMA; this effect was inhibited by all-trans-RA. Transient transfection experiments showed that PMA caused about a 2-fold increase in Cox-2 promoter activity, an effect that was suppressed by all-trans-RA. Our data indicate that treatment of oral epithelial cells with PMA is associated with enhanced transcription of Cox-2 and increased production of PGE2. These effects of PMA were inhibited by retinoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067275

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.

Authors:  P E Kish; M Blaivas; M Strawderman; K M Muraszko; D A Ross; B D Ross; G McMahon
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

Review 3.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 4.  Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications.

Authors:  A Gescher; U Pastorino; S M Plummer; M M Manson
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

5.  Induction of cyclo-oxygenase-2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK.

Authors:  W W Lin; B C Chen
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Ethanol extract of Elaeocarpus petiolatus inhibits lipopolysaccharide-induced inflammation in macrophage cells.

Authors:  Ok-Kyoung Kwon; Kyung-Seop Ahn; Ji-Won Park; Ha-Young Jang; Hyouk Joung; Hyeong-Kyu Lee; Sei-Ryang Oh
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 7.  Novel management of oral cancer: a paradigm of predictive oncology.

Authors:  Jon Sudbø
Journal:  Clin Med Res       Date:  2004-11

8.  The transcriptional activation of the cyclooxygenase-2 gene in zymosan-activated macrophages is dependent on NF-kappa B, C/EBP, AP-1, and CRE sites.

Authors:  Roberto Christ Vianna Santos; Miguel Angel Peña Rico; Ramon Bartrons; Francesc Ventura Pujol; Jose Luis Rosa; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

9.  17-Beta estradiol enhances prostaglandin E2 production in human U937-derived macrophages.

Authors:  Biao Lu; Yan J Jiang; Patrick C Choy
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

10.  The chemopreventive effect of retinoids on cellular NF-kappaB activity induced by NMU and NEU in human malignant keratinocytes.

Authors:  Ki-Young Moon
Journal:  Cancer Res Treat       Date:  2007-06-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.